Couples Coping Together Against Cancer: A Feasibility and Acceptability Look

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study enrolls patients with cancer and their partners who are treated at City of Hope and uses the Connecting Care App to deliver biopsychosocial screening and psychoeducation sessions. Participants may also receive up to four counseling sessions, each 30–45 minutes, with surveys completed throughout the study. The primary goals are to determine the feasibility and acceptability of the program components, while an exploratory objective looks for signals of reduced biopsychosocial distress in patients and partners over time. The program is non-interventional and focuses on integrating patient-partner support within standard care. The study includes adults who speak English or Spanish, have a compatible tech setup, and are in a committed relationship with a participating partner.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Have received a diagnosis of a primary brain tumor (glioblastoma), or other cancers (breast, lung, etc.)
* Are new patients to City of Hope (COH) (all sites) or receive at least some of their care at City of Hope- Duarte Campus (care is defined as: procedures, consults, laboratories, imaging, surgery, and/or treatment)
* The patient is in a committed relationship/partnership with a partner and the partner is available and willing to participate
* Are English or Spanish speaking
* ≥ 18 years of age
* Have access to a smartphone, computer/laptop or internet connection to complete all study procedures

Exclusion Criteria:

* Significant cognitive impairment
* Inpatient psychiatric treatment for severe mental illness or overt signs of severe psychopathology (e.g., psychosis)
* Visual, hearing, voice, or motor impairment that prevents completion of study procedures as evidenced by clinical judgment
* Committed partners will be excluded from the study if they:

  * Refuse to complete informed consent
  * Have cognitive impairment
  * Have severe mental illness that would prevent informed consent and completion of study activities as evidenced by clinical judgment

Where it's running

• City of Hope Medical Center
  Duarte, California, United States Recruiting

Study contacts

• Principal investigator: William Dale — City of Hope Medical Center

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

• Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors

  This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.

  Recruiting Phase 1 M.D. Anderson Cancer Center · Houston, Texas · NCT05092373

• Real-time imaging of tumor blood vessels during surgery

  We will test whether a real-time microscope technique during surgery can show how well blood vessels in adults' solid tumors work and whether that helps predict if systemic cancer medicines can reach the tumor.

  Recruiting Mayo Clinic · Jacksonville, Florida · NCT03823144

• Living Well with Advanced Breast Cancer: Understanding Supportive Care Needs

  This project asks adults with advanced (stage IV) breast cancer and their caregivers about what supportive care has helped, what’s been hard, and what help they still need.

  Recruiting Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT07227038

• Leuprolide versus goserelin to stop ovarian estrogen production in pre- or peri-menopausal women with breast cancer

  This study tests whether two doses of leuprolide or goserelin better stops the ovaries from making estrogen in pre- or peri-menopausal women with breast cancer.

  Recruiting Phase 2 University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT07158021

• Safety of combining pidnarulex (CX-5461) with trastuzumab deruxtecan for HER2-positive, HER2-low/ultralow breast and other HER2-expressing solid tumors

  This trial tests whether adding pidnarulex to trastuzumab deruxtecan is safe and finds the best dose for adults with HER2-positive, HER2-low/ultralow, or other HER2-expressing advanced or metastatic breast and solid tumors.

  Recruiting at 2 sites Phase 1 National Cancer Institute (NCI) · Boston, Massachusetts and 1 other locations · NCT07137416

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.